Accuray Incorporated (ARAY)
USD 1.79
(-6.28%)
USD 1.79
(-6.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 5.7 Million USD | -40.59% |
| 2023 | 9.6 Million USD | -70.77% |
| 2022 | 13.66 Million USD | -63.36% |
| 2021 | 28.62 Million USD | 87.35% |
| 2020 | 20.08 Million USD | 1935.68% |
| 2019 | 11.07 Million USD | 115.35% |
| 2018 | 1.67 Million USD | 61.35% |
| 2017 | 6.8 Million USD | -101.58% |
| 2016 | 12.58 Million USD | 74.58% |
| 2015 | -1.77 Million USD | -5.65% |
| 2014 | 2.49 Million USD | 77.5% |
| 2013 | -57.84 Million USD | -60.94% |
| 2012 | -35.45 Million USD | -148.42% |
| 2011 | -18.42 Million USD | -811.35% |
| 2010 | 9.99 Million USD | 217.29% |
| 2009 | 7.32 Million USD | -135.8% |
| 2008 | 14.11 Million USD | 452.87% |
| 2007 | 1.39 Million USD | 93.55% |
| 2006 | -29.68 Million USD | -30.18% |
| 2005 | -22.8 Million USD | -216.53% |
| 2004 | 19.56 Million USD | 223.18% |
| 2003 | -15.88 Million USD | -182.08% |
| 2002 | 19.35 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 8.32 Million USD | 689.1% |
| 2024 FY | - USD | 169.06% |
| 2024 Q1 | 4.09 Million USD | 3.71% |
| 2024 Q2 | -2.99 Million USD | -223.41% |
| 2024 Q3 | -2.96 Million USD | 66.95% |
| 2023 Q1 | -2.18 Million USD | -206.54% |
| 2023 Q4 | -457 Thousand USD | -119.73% |
| 2023 Q3 | 2.31 Million USD | -14.38% |
| 2023 Q2 | 2.7 Million USD | 223.97% |
| 2023 FY | - USD | -70.77% |
| 2022 Q4 | 2.04 Million USD | 84.34% |
| 2022 Q3 | 1.11 Million USD | -72.09% |
| 2022 FY | - USD | -63.36% |
| 2022 Q1 | 2.41 Million USD | -41.79% |
| 2022 Q2 | 3.98 Million USD | 65.12% |
| 2021 Q4 | 4.14 Million USD | -6.42% |
| 2021 Q1 | 5.46 Million USD | 20.02% |
| 2021 FY | - USD | 87.35% |
| 2021 Q2 | 8.19 Million USD | 49.95% |
| 2021 Q3 | 4.42 Million USD | -46.02% |
| 2020 Q1 | -4.28 Million USD | -231.37% |
| 2020 Q2 | 3.62 Million USD | 184.65% |
| 2020 Q3 | 7.96 Million USD | 119.96% |
| 2020 Q4 | 4.55 Million USD | -42.83% |
| 2020 FY | - USD | 1935.68% |
| 2019 Q4 | 3.25 Million USD | 13.09% |
| 2019 FY | - USD | 115.35% |
| 2019 Q1 | -4.68 Million USD | -251.57% |
| 2019 Q2 | -868 Thousand USD | 81.48% |
| 2019 Q3 | 2.88 Million USD | 431.91% |
| 2018 Q1 | -2.05 Million USD | -172.9% |
| 2018 Q2 | -1.01 Million USD | 50.44% |
| 2018 FY | - USD | 61.35% |
| 2018 Q3 | -1.44 Million USD | -41.69% |
| 2018 Q4 | 3.09 Million USD | 314.64% |
| 2017 FY | - USD | -101.58% |
| 2017 Q4 | 2.81 Million USD | 322.0% |
| 2017 Q3 | -1.26 Million USD | 73.71% |
| 2017 Q1 | -6.54 Million USD | -121.18% |
| 2017 Q2 | -4.82 Million USD | 26.33% |
| 2016 Q2 | -124 Thousand USD | 96.77% |
| 2016 Q1 | -3.84 Million USD | -160.01% |
| 2016 Q3 | 5.44 Million USD | 4488.71% |
| 2016 Q4 | -2.96 Million USD | -154.39% |
| 2016 FY | - USD | 74.58% |
| 2015 Q2 | -3.59 Million USD | 76.49% |
| 2015 FY | - USD | -5.65% |
| 2015 Q4 | -1.47 Million USD | -226.11% |
| 2015 Q3 | 1.17 Million USD | 132.64% |
| 2015 Q1 | -15.27 Million USD | -227.23% |
| 2014 Q3 | -475 Thousand USD | 33.66% |
| 2014 Q1 | -6.83 Million USD | 46.26% |
| 2014 Q2 | -716 Thousand USD | 89.53% |
| 2014 Q4 | -4.66 Million USD | -882.53% |
| 2014 FY | - USD | 77.5% |
| 2013 Q4 | -12.72 Million USD | 49.17% |
| 2013 Q1 | -9.74 Million USD | 19.52% |
| 2013 Q3 | -25.03 Million USD | -54.8% |
| 2013 Q2 | -16.17 Million USD | -65.98% |
| 2013 FY | - USD | -60.94% |
| 2012 FY | - USD | -148.42% |
| 2012 Q4 | -12.1 Million USD | -124.58% |
| 2012 Q1 | -13.51 Million USD | 30.13% |
| 2012 Q2 | -2.79 Million USD | 79.29% |
| 2012 Q3 | -5.39 Million USD | -92.67% |
| 2011 Q4 | -19.33 Million USD | -3428.47% |
| 2011 Q3 | -548 Thousand USD | -112.15% |
| 2011 Q2 | 4.51 Million USD | 170.96% |
| 2011 Q1 | -6.35 Million USD | -163.24% |
| 2011 FY | - USD | -811.35% |
| 2010 Q4 | 10.05 Million USD | 115.78% |
| 2010 Q3 | 4.65 Million USD | 791.1% |
| 2010 Q2 | -674 Thousand USD | 81.39% |
| 2010 Q1 | -3.62 Million USD | -143.66% |
| 2010 FY | - USD | 217.29% |
| 2009 Q4 | 8.29 Million USD | 321.92% |
| 2009 Q2 | 1.55 Million USD | 159.65% |
| 2009 Q1 | -2.6 Million USD | -340.96% |
| 2009 FY | - USD | -135.8% |
| 2009 Q3 | 1.96 Million USD | 26.76% |
| 2008 Q4 | 1.07 Million USD | 3.55% |
| 2008 Q2 | 2.67 Million USD | 36.74% |
| 2008 FY | - USD | 452.87% |
| 2008 Q1 | 1.95 Million USD | 43.58% |
| 2008 Q3 | 1.04 Million USD | -61.06% |
| 2007 FY | - USD | 93.55% |
| 2007 Q1 | 2.29 Million USD | 103.27% |
| 2007 Q2 | -5.85 Million USD | -355.36% |
| 2007 Q3 | -93 Thousand USD | 98.41% |
| 2007 Q4 | 1.36 Million USD | 1565.59% |
| 2006 Q3 | 16.34 Million USD | 0.0% |
| 2006 Q1 | 3.87 Million USD | 109.29% |
| 2006 FY | - USD | -30.18% |
| 2006 Q2 | 16.34 Million USD | 322.16% |
| 2006 Q4 | -70.04 Million USD | -528.63% |
| 2005 Q1 | 5.59 Million USD | 0.0% |
| 2005 Q3 | 5.59 Million USD | 0.0% |
| 2005 Q2 | 5.59 Million USD | 0.0% |
| 2005 Q4 | -41.66 Million USD | -844.83% |
| 2005 FY | - USD | -216.53% |
| 2004 FY | - USD | 223.18% |
| 2003 FY | - USD | -182.08% |
| 2002 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Envoy Medical, Inc. | -18.23 Million USD | 131.303% |
| Delcath Systems, Inc. | -46.11 Million USD | 112.381% |
| Xylo Technologies Ltd. | -12.18 Million USD | 146.841% |